DURATA THERAPEUTICS INC COM STK (DE)
DRTX
DRTX was delisted on the 17th of November, 2014.
70 hedge funds and large institutions have $172M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 15 closing their positions.
173% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 74 → 70 (-4)
25% less capital invested
Capital invested by funds: $229M → $172M (-$57.3M)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
81% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $5.88M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.76M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$914K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$813K |
| 4 |
AIG
American International Group
New York
|
+$614K |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$582K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.13M |
| 2 |
Jane Street
New York
|
-$1.13M |
| 3 |
Morgan Stanley
New York
|
-$761K |
| 4 |
SIM
Spark Investment Management
New York
|
-$671K |
| 5 |
Millennium Management
New York
|
-$646K |
DRTX Hedge Fund Activity: Q3 2014 in Review
70 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q3 2014, worth a combined $172M — down 25% from $229M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of DRTX and 11 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 30 added.
The largest buyer was Fidelity Investments, adding an estimated $1.76M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $1.13M sold.
- 70 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q3 2014, down from 74 in Q2 2014.
- Funds reported $172M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q3 2014, down 25% quarter-over-quarter.
- 11 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q3 2014 and 15 closed out, a net change of -4 holders.
- The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q3 2014 was Fidelity Investments, an estimated $1.76M added.
- The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q3 2014 was Renaissance Technologies, an estimated $1.13M sold.
Based on aggregated 13F filings for Q3 2014.